about
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsExome sequencing identifies recurrent somatic RAC1 mutations in melanomaDetecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.MicroRNA signatures differentiate melanoma subtypes.Phosphoproteomic screen identifies potential therapeutic targets in melanoma.
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
YULAC
@de
YULAC
@en
YULAC
@fr
YULAC
@ga
YULAC
@nl
type
label
YULAC
@de
YULAC
@en
YULAC
@fr
YULAC
@ga
YULAC
@nl
prefLabel
YULAC
@de
YULAC
@en
YULAC
@fr
YULAC
@ga
YULAC
@nl